References
- Al-Wadei HA, Schuller HM (2009). Nicotinic receptor-associated modulation of stimulatory and inhibitory neurotransmitters in NNK-induced adenocarcinoma of the lungs and pancreas. J Pathol, 218, 437-45. https://doi.org/10.1002/path.2542
- Al-Wadei HA, Plummer HK, Schuller HM (2009). Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter gamma-aminobutyric acid. Carcinogenesis, 30, 506-11. https://doi.org/10.1093/carcin/bgp010
- Al-Wadei HA, Al-Wadei MH, Ullah MF, et al (2012). Gamma-amino butyric acid inhibits the nicotine-imposed stimulatory challenge in xenograft models of non-small cell lung carcinoma. Curr Cancer Drug Targets, 12, 97-106. https://doi.org/10.2174/156800912799095171
-
Al-Wadei HA, Ullah MF, Al-Wadei MH (2012). Intercepting neoplastic progression in lung malignancies via the beta adrenergic (
${\beta}$ -AR) pathway: implications for anti-cancer drug targets. Pharmacol Res, 66, 33-40. https://doi.org/10.1016/j.phrs.2012.03.014 - Al-Wadei HA, Al-Wadei MH, Schuller HM (2012). Cooperative regulation of non-small cell lung carcinoma by nicotinic and beta-adrenergic receptors: a novel target for intervention. PLoS One, 7, 29915. https://doi.org/10.1371/journal.pone.0029915
- Arredondo J, Chernyavsky AI, Grando SA (2006). Nicotinic receptors mediate tumorigenic action of tobacco-derived nitrosamines on immortalized oral epithelial cells. Cancer Biol Ther, 5, 511-7. https://doi.org/10.4161/cbt.5.5.2601
- Ben-Eliyahu S, Shakhar G, Page GG, et al (2000). Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines andbeta-adrenoceptors. Neuroimmunomodulation, 8, 154-64. https://doi.org/10.1159/000054276
- Carlisle DL, Liu X, Hopkins TM, et al (2007). Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells. Pulm Pharmacol Ther, 20, 629-41. https://doi.org/10.1016/j.pupt.2006.07.001
- Catassi A, Servent D, Paleari L, et al (2008). Multiple roles of nicotine on cell proliferation and inhibition of apoptosis: implications on lung carcinogenesis. Mutat Res, 659, 221-31. https://doi.org/10.1016/j.mrrev.2008.04.002
- Cole SW, Sood AK (2012). Molecular pathways: beta-adrenergic signaling in cancer. Clin Cancer Res, 18, 1201-6. https://doi.org/10.1158/1078-0432.CCR-11-0641
- Drell TL, Joseph J, Lang K, et al (2003). Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells. Breast Cancer Res Treat, 80, 63-70. https://doi.org/10.1023/A:1024491219366
- Jemal A, Siegel R, Ward E, et al (2007). Cancer statistics, 2007. CA Cancer J Clin, 57, 43-66. https://doi.org/10.3322/canjclin.57.1.43
- Kondratenko TIa, Kuzina NV, Severin ES, et al (1991). Beta-Adrenergic and muscarinic acetylcholine receptors in human lung parenchyma in malignant neoplasms. Vopr Med Khim, 37, 20-1.
- Kondratenko TY, Zacharova IV, Kuzina NV, et al (1993). Alterations in human lung adrenergic receptors in cancer. Biochem Mol Biol Int, 29, 123-30.
- Laag E, Majidi M, Cekanova M, et al (2006). NNK activates ERK1/2 and CREB/ATF-1 via beta-1-AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cells. Int J Cancer, 119, 1547-52. https://doi.org/10.1002/ijc.21987
- Masur K, Niggemann B, Zanker KS, et al (2001). Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res, 61, 2866-9.
- Morin D, Zini R, Lange F, et al (1987). Alterations of beta-adrenergic, muscarinic cholinergic receptors and imipramine binding sites in human lungtumors. Int J Clin Pharmacol Ther Toxicol, 25, 605-8.
- Palm D, Lang K, Niggemann B, et al (2006). The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers. Int J Cancer, 118, 2744-9. https://doi.org/10.1002/ijc.21723
- Powe DG, Voss MJ, Zanker KS, et al (2010). Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improvescancer specific survival. Oncotarget, 1, 628-38.
- Salpeter SS, Ormiston T, Salpeter E, et al (2002). Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 2, 3566.
- Schuller HM, Orloff M (1998). Tobacco-specific carcinogenic nitrosamines. Ligands for nicotinic acetylcholine receptors in human lung cancer cells. Biochem Pharmacol, 55, 1377-83. https://doi.org/10.1016/S0006-2952(97)00651-5
- Schuller HM, Tithof PK, Williams M, et al (1999). The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via beta-adrenergic receptor-mediated release of arachidonic acid. Cancer Res, 59, 4510-5.
- Schuller HM, Porter B, Riechert A (2000). Beta-adrenergic modulation of NNK-induced lung carcinogenesis in hamsters. J Cancer Res Clin Oncol, 126, 624-30. https://doi.org/10.1007/PL00008474
- Schuller HM, Cekanova M (2005). NNK-induced hamster lung adenocarcinomas over-express beta2-adrenergic and EGFR signaling pathways. Lung Cancer, 49, 35-45. https://doi.org/10.1016/j.lungcan.2004.12.012
- Schuller HM (2008). Neurotransmission and cancer: implications for prevention and therapy. Anticancer Drugs, 19, 655-71. https://doi.org/10.1097/CAD.0b013e3283025b58
- Schuller HM (2009). Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? Nat Rev Cancer, 9, 195-205. https://doi.org/10.1038/nrc2590
-
Shah SM, Carey IM, Owen CG, et al (2011). Does
${\beta}$ -adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study. Br J Clin Pharmacol, 72, 157-61. https://doi.org/10.1111/j.1365-2125.2011.03980.x - Sood AK, Bhatty R, Kamat AA, et al (2006). Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res, 12, 369-75. https://doi.org/10.1158/1078-0432.CCR-05-1698
- Thaker PH, Han LY, Kamat AA, et al (2006). Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med, 12, 939-44. https://doi.org/10.1038/nm1447
- Wang HM, Liao ZX, Komaki R, et al (2013). Improved survival outcomes with the incidental use of beta-blockers among patients with non-small -cell lung cancer treated with definitive radiation therapy. Ann Oncol, 24, 1312-9. https://doi.org/10.1093/annonc/mds616
- West KA, Linnoila IR, Belinsky SA, et al (2004). Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3'-kinase/Akt pathway in vitro and in vivo. Cancer Res, 64, 446-51. https://doi.org/10.1158/0008-5472.CAN-03-3241
- Wong HP, Yu L, Lam EK, et al (2007). Nicotine promotes colon tumor growth and angiogenesis through beta-adrenergic activation. Toxicol Sci, 97, 279-87. https://doi.org/10.1093/toxsci/kfm060
- Wong HP, Yu L, Lam EK, et al (2007). Nicotine promotes cell proliferation via alpha7-nicotinic acetylcholine receptor and catecholamine-synthesizing enzymes-mediated pathway in human colon adenocarcinoma HT-29 cells. Toxicol Appl Pharmacol, 221, 261-7. https://doi.org/10.1016/j.taap.2007.04.002
- Wong DL, Tai TC, Wong-Faull DC, et al (2011). Epinephrine: a short- and long-term regulator of stress and development of illness: a potential new role for epinephrine in stress. Cell Mol Neurobiol, 32, 737-48.
Cited by
- Radiosensitization Effect of Overexpression of Adenovirus-mediated SIRT6 on A549 Non-small Cell Lung Cancer Cells vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7297
- Expression of ERCC1, RRM1 and LRP in Non-small Cell Lung Cancers and their Influence on Chemotherapeutic Efficacy of Gemcitabine Concomitant with Nedaplatin vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7303
- Experimental Study on Inhibition Effects of the XAF1 Gene against Lung Cancer Cell Proliferation vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7825
- Are Beta Blockers New Potential Anticancer Agents? vol.15, pp.22, 2014, https://doi.org/10.7314/APJCP.2014.15.22.9567
- Sympathetic nervous system regulation of the tumour microenvironment vol.15, pp.9, 2015, https://doi.org/10.1038/nrc3978
- β-Blocker use and mortality in cancer patients vol.25, pp.5, 2016, https://doi.org/10.1097/CEJ.0000000000000192
- Propranolol enhances bone healing and implant osseointegration in rats tibiae vol.43, pp.12, 2016, https://doi.org/10.1111/jcpe.12632
- Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study vol.7, pp.1, 2017, https://doi.org/10.1038/s41598-017-02913-8
- Infantile Hemangiomas, Retinopathy of Prematurity and Cancer: A Common Pathogenetic Role of the β-Adrenergic System vol.35, pp.3, 2015, https://doi.org/10.1002/med.21336
- Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation vol.18, pp.1, 2018, https://doi.org/10.1186/s12885-018-4509-0